Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
Yuzhi Jin, Yangyue Huang, Hui Ren, et al.
Biomaterials (2024) Vol. 305, pp. 122463-122463
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
NIR‐Actuated Ferroptosis Nanomotor for Enhanced Tumor Penetration and Therapy
Ziwei Hu, Haixin Tan, Yicheng Ye, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 10
Tumor vascular endothelial cells promote immune escape by upregulating PD-L1 expression via crosstalk between NF-κB and STAT3 signaling pathways in nasopharyngeal carcinoma
Yan Wang, Yuanyuan Chen, Yuanyuan Liu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Digging Through the Complexities of Immunological Approaches in Emerging Osteosarcoma Therapeutics: A Comprehensive Narrative Review with Updated Clinical Trials
Consolato Sergi, Mervin Burnett, Eugeniu Jantuan, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 664-664
Open Access | Times Cited: 1
Emerging Role of Extracellular pH in Tumor Microenvironment as a Therapeutic Target for Cancer Immunotherapy
Md. Ataur Rahman, Mahesh Kumar Yadab, Meser M. Ali
Cells (2024) Vol. 13, Iss. 22, pp. 1924-1924
Open Access | Times Cited: 8
Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy
José L. Blaya-Cánovas, Carmen Griñán‐Lisón, Isabel Blancas, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Disulfiram-loaded CuO2 nanocarriers for enhanced synergistic chemodynamic chemotherapy
Wei Hu, Lianlian Yang, Hongtao Liao, et al.
Journal of Colloid and Interface Science (2024) Vol. 674, pp. 9-18
Closed Access | Times Cited: 5
Advances in and prospects of immunotherapy for prostate cancer
Deng Liu, Luofu Wang, Yanli Guo
Cancer Letters (2024) Vol. 601, pp. 217155-217155
Open Access | Times Cited: 5
Better together: nanoscale co-delivery systems of therapeutic agents for high-performance cancer therapy
Liyan Sun, Zhe Li, Jinshuai Lan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Bacterial outer membrane vesicles-clothed nanoparticles delivered by live macrophages for potentiating antitumor photoimmunotherapy
Cong Fu, Lu Tang, Yuqi Cao, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156420-156420
Closed Access | Times Cited: 4
Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies
Sahar Balkhi, Giorgia Bilato, Andrea De Lerma Barbaro, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 69-69
Open Access
Photochemical bomb: Precision nuclear targeting to activate cGAS-STING pathway for enhanced bladder cancer immunotherapy
Dexiang Feng, Xiaoying Kang, He Wang, et al.
Biomaterials (2025), pp. 123126-123126
Closed Access
Organometallic-based pyroptotic inducers for cancer immunotherapy
Jie Xu, Yang Ce-yao, Qi Yu
Journal of Organometallic Chemistry (2025), pp. 123571-123571
Closed Access
Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells
Zebo Jiang, Qiang He, Liping Kang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access
Injectable celastrol-loading emulsion hydrogel for immunotherapy of low-immunogenic cancer
Yu Liu, Jia Zhang, Chun-Yu Lai, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Immunomodulation on tumor immune microenvironment in acquired targeted therapy resistance and implication for immunotherapy resistance
Ming-Yu Chou, Muh‐Hwa Yang
Translational Oncology (2025) Vol. 54, pp. 102353-102353
Closed Access
Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy
Alicia Arroyo-Nogales, Guillermo Plaza-Palomo, Javier Gónzalez‐Larre, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1257-1257
Open Access
Inorganic Nanomaterials Meet the Immune System: An Intricate Balance
Gloria Pizzoli, Marco Gargaro, Giuliana Drava, et al.
Advanced Healthcare Materials (2025)
Open Access
Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials
Yanan Niu, Junya Feng, Jie Ma, et al.
Exploration (2025)
Open Access
Reversing cancer immunosuppression via K+ capture and repolarization of tumor-associated macrophages
Si‐Ye Tong, Cong‐Min Huo, Yu‐Cheng Zuo, et al.
Nanoscale Horizons (2025)
Closed Access
Nano-strategies for Targeting Tumor-Associated Macrophages in Cancer immunotherapy
Qian Li, Jingwei Xu, Rong Hua, et al.
Journal of Cancer (2025) Vol. 16, Iss. 7, pp. 2261-2274
Open Access
Combating cancer immunotherapy resistance: a nano‐medicine perspective
Xiangyi Kong, Xintong Xie, Juan Wu, et al.
Cancer Communications (2025)
Open Access
Remodeling of Effector and Regulatory T Cells by Capture and Utilization of miRNAs Using Nanocomposite Hydrogel for Tumor-Specific Photothermal Immunotherapy
Li Chen, Man Zhu, Handan Zhang, et al.
ACS Nano (2025)
Closed Access
Multi-functional lipid nanoformulations for enhancing the efficacy of mRNA tumor vaccines by reversing tumor immunosuppressive microenvironment
Yufeng Zhang, Liuwei Zhang, Hui Gao, et al.
Nano Today (2025) Vol. 63, pp. 102757-102757
Closed Access
Peptide-based drugs in immunotherapy: current advances and future prospects
Dipanjan Karati, Shreyasi Meur, Soumi Das, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Page 1 - Next Page

Scroll to top